Literature DB >> 22657266

Representation of older adults in the late-breaking clinical trials American Heart Association 2011 Scientific Sessions.

Philip Green, Mathew S Maurer, Joanne M Foody, Daniel E Forman, Nanette K Wenger.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22657266      PMCID： PMC3715882          DOI： 10.1016/j.jacc.2012.03.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  26 in total

1.  Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.

Authors:  Richard Lowrie; Frances S Mair; Nicola Greenlaw; Paul Forsyth; Pardeep S Jhund; Alex McConnachie; Brian Rae; John J V McMurray
Journal:  Eur Heart J       Date:  2011-11-14       Impact factor: 29.983

2.  Ethnic-specific prevalence of peripheral arterial disease in the United States.

Authors:  Matthew A Allison; Elena Ho; Julie O Denenberg; Robert D Langer; Anne B Newman; Richard R Fabsitz; Michael H Criqui
Journal:  Am J Prev Med       Date:  2007-04       Impact factor: 5.043

3.  Age disparities in heart failure research.

Authors:  Dalane W Kitzman; Michael W Rich
Journal:  JAMA       Date:  2010-11-03       Impact factor: 56.272

4.  Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Authors:  Stephen J Nicholls; H Bryan Brewer; John J P Kastelein; Kathryn A Krueger; Ming-Dauh Wang; Mingyuan Shao; Bo Hu; Ellen McErlean; Steven E Nissen
Journal:  JAMA       Date:  2011-11-16       Impact factor: 56.272

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy.

Authors:  Massimo Imazio; Antonio Brucato; Paolo Ferrazzi; Maria Elena Rovere; Anna Gandino; Roberto Cemin; Stefania Ferrua; Riccardo Belli; Silvia Maestroni; Caterina Simon; Edoardo Zingarelli; Alberto Barosi; Fabrizio Sansone; Davide Patrini; Ettore Vitali; Rita Trinchero; David H Spodick; Yehuda Adler
Journal:  Circulation       Date:  2011-11-16       Impact factor: 29.690

7.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

Authors:  M D Silverstein; J A Heit; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1998-03-23

8.  Cardiac care for older adults. Time for a new paradigm.

Authors:  Daniel E Forman; Michael W Rich; Karen P Alexander; Susan Zieman; Mathew S Maurer; Samer S Najjar; Joseph C Cleveland; Harlan M Krumholz; Nanette K Wenger
Journal:  J Am Coll Cardiol       Date:  2011-05-03       Impact factor: 24.094

9.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

Authors:  M Senni; C M Tribouilloy; R J Rodeheffer; S J Jacobsen; J M Evans; K R Bailey; M M Redfield
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

10.  The exclusion of the elderly and women from clinical trials in acute myocardial infarction.

Authors:  J H Gurwitz; N F Col; J Avorn
Journal:  JAMA       Date:  1992-09-16       Impact factor: 56.272
View more
  4 in total

1.  Time for a New Approach to Studying Older People with Ischemic Heart Disease.

Authors:  John A Dodson; Sarwat I Chaudhry; Harlan M Krumholz
Journal:  J Am Geriatr Soc       Date:  2017-05-11       Impact factor: 5.562

2.  Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Authors:  Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson
Journal:  Pharmacotherapy       Date:  2017-12-11       Impact factor: 4.705

3.  Disparities by sex in P2Y12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable men following acute myocardial infarction? A P2Y12 inhibitor new user retrospective cohort analysis of US Medicare claims data.

Authors:  Ryan P Hickson; Anna M Kucharska-Newton; Jo E Rodgers; Betsy L Sleath; Gang Fang
Journal:  BMJ Open       Date:  2021-12-01       Impact factor: 2.692

4.  Inclusion of Older People Reflective of Real-World Clinical Practice in Cardiovascular Drug Trials.

Authors:  Gillian E Caughey; Maria C Inacio; J Simon Bell; Agnes I Vitry; Sepehr Shakib
Journal:  J Am Heart Assoc       Date:  2020-10-26       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.